Navigation Links
NewLife Homecare Partners With ChronoMed to Offer Customized Nutritional Program for Bleeding Disorder Community
Date:3/15/2010

PITTSTON, Pa., March 15 /PRNewswire/ -- NewLife Homecare, a leading specialty pharmacy serving people with bleeding disorders, is proud to introduce an innovative and highly-customized nutrition program for the bleeding disorder community.  The program, a patented clinical assessment tool that evaluates several key factors of a person's health—lifestyle, physical well-being, medical conditions and history, and medications—and then customizes a comprehensive nutritional regimen, is offered through NewLife's website, www.newlifehomecare.com.  The technology, developed by ChronoMed for the general public, has been further enhanced for NewLife Homecare in order to reflect the specific needs of people living with bleeding disorders.  As a company well-known for its holistic approach to bleeding disorders, NewLife Homecare sees ChronoMed's program as a natural extension of the service it provides.

"We have always emphasized the importance of focusing on the whole person and their lifestyle rather than simply addressing the complications associated with the disease as they occur," said NewLife Homecare's President and CEO, Gregory Malia.  "This new program will allow our clients to benefit from a nutrition regimen in an entirely new way."  

Tom Fourt, Vice President Sales and Marketing for ChronoMed, sees NewLife Homecare as the ideal company to offer this program exclusively to the bleeding disorder community.  "NewLife's staff has a unique understanding of the needs of bleeding disorder patients," he said.  "This, combined with their holistic, proactive approach, has resulted in an unparalleled level of service.  As an integrative element to good health, ChronoMed is the perfect complement to this breadth of service."

A Program that Offers a New Level of Personalization

For NewLife's clients, the experience begins with a Healthstyle Risk Assessment, an online survey that speaks to the many complexities of hemophilia.  The questions are organized into six categories: Personal Data, which covers allergies and family history along with insightful queries such as how many hours a person is exposed to the sun each day, seasonality, and where in the US a person lives to determine levels of vitamin D; Dietary Patterns, which measures the daily consumption of foods ranging from vegetables and fruits to products like artificial sweeteners; Lifestyle, a look at a person's smoking, drinking, and sleeping habits; Physical Wellbeing, which covers exercise, joint pain, immune system protection, and stress; Conditions, an evaluation of every medical condition, chronic and otherwise, that a person lives with; and Medications—extremely relevant for people with bleeding disorders, this category includes an extensive database of brand name and generic drugs.  

Once the Healthstyle Risk Assessment is complete, patients are sent a personalized, clinically-driven nutrient recommendation, complete with doses and time-of-day instructions to maximize absorption.  Malia, who lives with severe hemophilia, is quick to point out that the program's extremely high level of personalization makes it an invaluable tool for people living with bleeding disorders.  "Given the technology's ability to consider how drugs interact with nutritional supplements, this program is particularly appropriate to our clients, people who take many medications every day just to manage their disease."  

Dawn Litchey, NewLife Homecare's client advocate, is the mother of four sons with severe hemophilia.  On NewLife's behalf, Litchey worked closely with ChronoMed to ensure the online assessment included the extremely wide range of drugs hemophiliacs need.  "Our clients, and my own children, require drugs that, while life-saving, can also deplete their bodies of nutrients," she said.  "By evaluating all the medications our clients are taking, we can ensure that the recommended nutrition plan is comprehensive enough to replenish all those nutrients and ultimately help prevent more serious systemic problems."

While NewLife Homecare's staff of pharmacists and patient advocates reviews every assessment, the company insists that clients consult with their physicians before taking any nutritional supplements.  Once the client and doctor are on board, NewLife works with ChronoMed to coordinate delivery to clients' homes.  To further simplify the process, supplements are shipped in daily use packs with clear instructions.  

NewLife Homecare's collaboration with ChronoMed is part of its commitment to help its clients enhance their overall health and wellness with proactive measures.  NewLife's clients have long considered the company a lifeline and invaluable resource.  Now, with the help of ChronoMed's groundbreaking technology, NewLife has taken this commitment a step further.  

ABOUT NEWLIFE HOMECARE

Founded in 2000, NewLife Homecare offers specialized pharmacy services to people living with chronic bleeding disorders and their families.  The company's comprehensive customer service model, holistic approach to patient care, and unprecedented level of advocacy within the bleeding disorder community has helped them set a new standard of practice within the specialty pharmacy category.  

SOURCE NewLife Homecare

Back to top

RELATED LINKS
http://www.newlifehomecare.com

'/>"/>

SOURCE NewLife Homecare
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. American Association for Homecare Backs Bipartisan Bill to Eliminate Medicare Bidding Program for Home Medical Equipment
2. American Association for Homecare Proposes Strong Anti-Fraud Measures in Medicare, Applauds HHS Testimony Today That Pledges to "Stop Fraud Before it Starts"
3. Home Medical Equipment Providers and Lawmakers Discuss Cost-Effective Role of Homecare During Washington Meeting
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
8. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
9. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
10. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature
11. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and ... results of its phase 3 EXPEDITION3 trial at the ... meeting. As previously disclosed, solanezumab did not meet the ... of solanezumab initiated in people with mild dementia due ... regulatory submissions for solanezumab for the treatment of mild ...
(Date:12/8/2016)... de dezembro de 2016  A Mederi Therapeutics Inc . anunciou aprovação ... não cirúrgico para a doença do refluxo gastroesofágico (DRGE). Foto -  ... ... Live Stretta procedure performed and broadcast during the Chinese ... Union Hospital , ...
(Date:12/8/2016)... Pa. , Dec. 8, 2016  Pennsylvania ... Secretary of Drug and Alcohol Programs Gary ... and insomnia medications, known as benzodiazepines, developed with ... "Benzodiazepines are medications that are frequently prescribed ... when they are used with opioid pain medications, ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, ... with the grand opening of the Sober College Robert Pfeifer Memorial Learning Center ... December 2-3, and was attended by an overwhelming amount of alumni, family, colleagues ...
(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):